Investors

Investors

IR-Med, Inc.

IR-Med, Inc.

Symbol: IRME

Designs and develops devices utilizing spectrographic usability medical devices based on the combination of Infra-Red (IR) and Artificial Intelligence (AI) technologies. The company was founded in 2012 and is headquartered in Rosh Pina, Israel.

Press Release

IR-Med’s PressureSafe Noninvasive Wound Care Device to be Demonstrated at Northwell Health’s 10th Annual Shining the Light on Wound Care Symposium

IR-Med to present at National Pressure Injury Advisory Panel 2023

IR-MED SIGNS AGREEMENT TO EXPAND ITS PRESSURESAFE DEVICE USABILITY STUDY

IR-Med Gains Momentum in 2022

IR-Med Announces Dr. David Dalton as Advisory Board member

IR-Med Signs Agreement for the Commercial Design of the PressureSafe Device

Financial Statments

May 15, 2023
10-Q - Period Ending 03/31/23
May 11, 2023
10-K/A Period Ending 12/31/22
March 29, 2023
10-K - Period Ending 12/31/22
November 14, 2022
10-Q - Period Ending 09/30/22
August 15, 2022
10-Q - Period Ending 06/30/22
May 16, 2022
10-Q - Period Ending 03/31/22

Conferences

NPIAP 2023 Annual Conference

March 17-18,2023


Equity in Prevention and Treatment of Pressure Injury